Implied volatility in Royal Dutch Shell (RDS.A) currently stands at 15%, which is lower than its 30-day average implied volatility of 18%.
Shell’s Integrated Gas segment reported a 27% fall in its 4Q16 earnings to $907 million over 4Q15’s earnings.
Year-to-date in 2017, Shell’s peers ExxonMobil (XOM), Chevron (CVX), and PetroChina (PTR) have fallen 10.8%, 10.1%, and 5.4%, respectively.
Royal Dutch Shell (RDS.A) is expected to release its 1Q17 results on May 4, 2017. According to analyst estimates, Shell is expected to post EPS of $0.84 in 1Q17.
To promote the use of Spinraza for SMA, Biogen (BIIB) has been actively educating and creating awareness for the drug among physician and patient communities.
Biogen (BIIB) has entered into a licensing agreement with Bristol-Myers Squibb (BMY) for exclusive global rights for the development and commercialization of BMS-986168.
In 1Q17, Biogen’s (BIIB) Spinraza earned revenues of $47.0 million, of which $46.0 million were from the US market.
In 1Q17, Biogen (BIIB) saw an increased demand for Tysabri, both in the United States and in international markets.
Spinraza, Biogen’s (BIIB) SMA (spinal muscular atrophy) therapy, was approved by the FDA (U.S. Food and Drug Administration) on December 23, 2016.
Biogen witnessed a slight contraction in demand for its MS products in the US market in 1Q17 on a quarter-over-quarter basis.
Biogen (BIIB) currently holds a 38.0% share of the global MS market. In 1Q17, the company reported revenues of around $2.2 billion for its MS franchise
Biogen (BIIB) reported its 1Q17 results on April 25, 2017. Its revenues were about $2.8 billion, which is a YoY (year-over-year) rise of about 3.0%.
Of the 13 analysts following Altria, 38.5% are recommending a “buy,” while 53.8% are recommending “hold,” and 7.7% are recommending “sell.”
As of April 25, 2017, Altria was trading at a PE multiple of 21.5x, as compared to 21.4x before the announcement of its 4Q16 earnings.
In 1Q17, analysts are expecting Altria Group (MO) to post a gross margin, EBITDA margin, and net margin of 59.7%, 49.9%, and 30.9%, respectively.
For 1Q17, analysts are expecting Altria Group (MO) to post EPS (earnings per share) of $0.74, which would represent a growth of 2.8% from $0.72 in 1Q16.
In 4Q16, the Smokeable segment made up 84% of Altria’s total revenues. The Smokeless, Wine, and Other segments made up 10.3%, 5.1%, and 0.6% of the total, respectively.
Altria Group (MO) is set to announce its 1Q17 earnings before the market opens on May 2. Altria is a holding company made up of six wholly-owned subsidiaries.
Network performance is the key factor that affects customer retention for a telecom company.
The capital-intensive telecom industry has high levels of depreciation and amortization as well as varying degrees of debt and operating leases.